Projects
Centre for R&D Monitoring. (ECOOM) University of Antwerp
R&D towards a High Rate Particle Detector for the CMS Experiment at the LHC Ghent University
In 2009, the Large Hadron Collider (LHC), the world’s most powerful accelerator became operational, producing mainly proton-proton collisions at multi-TeV center-of-mass energies. This allows experiments, such as the Compact Muon Solenoid (CMS), to explore the so-far uncharted physics at this energy scale. One of the, in the meantime world-famous results of the first LHC physics run that recently ended, is the discovery a new particle with ...
Building towards a patent - Exploitation of the killifish R&D platform to combat neurodegenerative diseases KU Leuven
R&D 2022: Switching PixEls robotiCs adopTion REsearch Vrije Universiteit Brussel
Joint R&D 2022: ECOPIPE: Energy Consumption Optimization in Pipeline-architectures. Vrije Universiteit Brussel
Policy recommendations for a pharmaceutical R&D and evaluation framework that is driven by unmet medical needs KU Leuven
The coronavirus pandemic has impacted scientific research and triggered the reconsideration of the regulatory pathways for drug development and evaluation. It appeared that a clear dialogues between drug developers in the profit and non-profit context, regulatory representatives (at the European Medicines Agency - EMA - and national authorities) as well as health technology assessment (HTA) bodies and payers are indispensable to enable ...
Exploring the market potential of photoporation as the next generation of intracellular delivery technology for the R&D and cell therapy markets Ghent University
Delivering macromolecular compounds into living cells in vitro or ex vivo is a common requirement for both fundamental biological research as well as biomedical applications. Examples include the intracellular delivery of gene editing molecules to unravel molecular pathways or to create engineered therapeutic cells. Photoporation, which combines laser irradiation with light-sensitive nanomaterials, is an upcoming physical intracellular ...
CARE Corona Accelerated R&D in Europe KU Leuven
The Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) pandemic has emerged as the largest global health threat to humanity in this century. According to the World Health Organisation Situation Report of March 28th 2020, 571,659 patients were diagnosed with Coronavirus Disease 2019 (COVID-19) and 26,493 deaths were reported globally. The wide spectrum of clinical symptoms, disease severity in high risk individuals, transmission ...
R&D Field Lab Etpathfinder Ghent University
ETpathfinder is a R&D infrastructure for testing and prototyping innovative concepts and enabling technologies for the Einstein Telescope, the first of a new class of future gravitational wave observatories.